Plain-English translation of NCT05665738 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to treating early-stage prostate cancer using high-dose rate brachytherapy—a type of internal radiation therapy where radioactive material is placed directly at the cancer site. Instead of receiving treatment over several days, participants would receive two full doses just three hours apart on a single day. The study wants to confirm this faster treatment is safe and works well for men with low to intermediate risk prostate cancer.
Standard brachytherapy for prostate cancer typically takes multiple days, which can be inconvenient and costly for patients. This trial is exploring whether delivering the same total radiation dose in just one day—with a three-hour break between treatments—could be equally effective while reducing the burden on patients.
You likely qualify if…
You likely don't qualify if…
You would come to the hospital or clinic for one full day of treatment. You'll receive two doses of focused radiation therapy placed inside the prostate, with a three-hour break between them. After treatment, you'll have follow-up appointments to check how well the treatment worked, starting with visits every three months for the first year, then less frequently over the next five years. Your doctor will monitor your PSA levels (a blood test that tracks prostate cancer) to see how your body is responding.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States